Have questions?

Purigen Biosystems, Inc.

Nucleic Acid Purification – Pure and Simple

About Purigen Biosystems

Purigen Biosystems' transformative Ionic Purification System provides a hands-free solution for extracting, enriching and quantifying DNA and RNA from biological samples. Our proprietary approach uses isotachophoresis (ITP), an electric-field-driven technique for purifying, focusing, and/or separating species. The application of ITP to purify and quantify nucleic acids from complex biological samples was pioneered by Purigen co-founder, Stanford Professor Juan G. Santiago. The Ionic® Purification System is compatible with a range of samples including cells and FFPE.

Purigen is proudly affliated with StartX Med, a Stanford-University-affliated nonprofit technology accelerator, and the California Life Sciences Institute’s (CLSI) FAST Advisory Program.

SmartX Med and Purigen Biosystems California Life Sciences Institute and Purigen Biosystems

Leadership Team

  • Klint Rose, Ph.D.
    CSO and Co-founder
  • Steve Reichenbach
    Consulting CFO
  • Chris Grimley
    SVP of Sales and Marketing

Board of Directors

  • Joseph J. Victor
    Executive Chairman of the Board of Directors
  • Scott M. Rocklage, Ph.D.
    Founding Partner – 5AM Ventures
  • Bill W. Colston, Ph.D.
    CEO of Sestina Bio
  • Simon Greenwood, Ph.D.
    Senior Investment Director – Roche Venture Fund
  • Jeffrey R. Sampson, Ph.D.
    Research Fellow - Agilent

Scientific Advisory Board

  • Juan Santiago, Ph.D.
    Scientific Advisor and Co-founder
  • Doug Amorese
    CSO, Tecan Genomics
  • Sean C. Bendall, Ph.D.
    Assistant Professor of Pathology, Stanford University